Time to normalisation of C-reactive protein and incidence of relapse in microscopic polyangiitis: A medical records review study in Japan
Modern Rheumatology · 2023
DOI: 10.1093/mr/roac146 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Rheumatology, 2023. Verfasst von Makoto Yamaguchi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Rheumatology, Aichi Medical University, Nagakute, Aichi, Japan. Hauptthemen laut MEDLINE: Microscopic Polyangiitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Granulomatosis with Polyangiitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Objectives
Despite the identification of risk factors for relapses in antineutrophil cytoplasmic antibody-associated vasculitis, the relationship between changes in C-reactive protein (CRP) levels after the initial treatment and the incidence of relapse remains unknown. This study aimed to assess the association between the time taken for normalisation of CRP levels and the incidence of relapse in Japanese adult patients with microscopic polyangiitis.
Methods
This study included 85 consecutive patients with newly diagnosed microscopic polyangiitis who achieved remission after 6 months of immunosuppressive treatment at the Aichi Medical University Hospital between 2009 and 2017. The relationship between the time to normalisation of CRP after the initial immunosuppressive treatment and relapse incidences was evaluated using multivariable Cox proportional hazard models.
Results
During the follow-up period, 13 (30.2%), 7 (41.2%), and 16 (64.0%) patients relapsed (P = .025) within 1–14, 15–28, and ≥29 days of normalisation, respectively. The hazard ratios [95% confidence intervals (CIs)] for the time to normalisation of CRP of 1–14, 15–28, and ≥29 days were 1.00 (reference), 2.42 (95% CI: 0.92–6.39), and 3.48 (95% CI: 1.56–7.76), respectively.
Conclusions
A significant association between the time to normalisation of CRP and the relapse incidence in Japanese patients with microscopic polyangiitis was observed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology and Rheumatology, Aichi Medical University, Nagakute, Aichi, Japan.
- Department of Nephrology and Rheumatology, Aichi Medical University Medical Center, Okazaki, Aichi, Japan.
- Department of Advanced Medicine, Data Coordinating Center, Nagoya University Hospital, Nagoya, Japan.
- Department of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
ORCID-Profile: Takuji Ishimoto
Zitieren
APA
Yamaguchi, M., Ito, M., Sugiyama, H., Iwagaitsu, S., Nobata, H., Kinashi, H., Katsuno, T., Ando, M., Kubo, Y., Banno, S., Ito, Y., & Ishimoto, T. (2023). Time to normalisation of C-reactive protein and incidence of relapse in microscopic polyangiitis: A medical records review study in Japan. Modern Rheumatology. https://doi.org/10.1093/mr/roac146
Vancouver
Yamaguchi M, Ito M, Sugiyama H, Iwagaitsu S, Nobata H, Kinashi H, et al. Time to normalisation of C-reactive protein and incidence of relapse in microscopic polyangiitis: A medical records review study in Japan. Modern Rheumatology. 2023. doi:10.1093/mr/roac146
BibTeX
@article{Yamaguchi2023,
author = {Yamaguchi, Makoto and Ito, Mayumi and Sugiyama, Hirokazu and Iwagaitsu, Shiho and Nobata, Hironobu and Kinashi, Hiroshi and Katsuno, Takayuki and Ando, Masahiko and Kubo, Yoko and Banno, Shogo and Ito, Yasuhiko and Ishimoto, Takuji},
title = {Time to normalisation of C-reactive protein and incidence of relapse in microscopic polyangiitis: A medical records review study in Japan},
journal = {Modern Rheumatology},
year = {2023},
doi = {10.1093/mr/roac146}
}
EUVIMED